Purchase Order 75F40121P00588
Award Date 9/21/21
Potential Completion Date 9/20/24
Potential Value $34K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award from the National Cancer Institute (NCI), a civilian agency, to the International Union Against Cancer (UICC), a non-profit organization. The purpose of this $542,725.00 definitive contract is to facilitate international scientific cooperation in cancer research through the exchange visits of scientists. The contract is not set-aside. It began on September 30, 2009 and is scheduled to be completed by September 29, 2014. The contract aims to promote the direct and...
- This federal contract award was made by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to the Centre International De Recherche SUR LE Cancer (IARC), an international non-profit organization. The $75,000.00 firm fixed-price purchase order contract supports research on coffee-associated metabolites in relation to liver cancer and liver disease mortality in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) study. The contract does...
- This is a $547,860 delivery order contract awarded by the National Cancer Institute (NCI) of the Department of Health and Human Services (HHS) to The Institute for Cancer Research, a non-profit research organization. The contract is part of the Preclinical Efficacy and Intermediate Endpoint Biomarkers indefinite delivery vehicle, which supports the PREVENT Cancer Preclinical Drug Development Program. Under this 5-year IDIQ, The Institute for Cancer Research provides preclinical efficacy...
- This is a firm fixed-price purchase order contract awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to Istituto Superiore DI Sanita' - ISS, a foreign government entity in Italy. The contract, valued at $79,994.00, is for extending code and methods to provide estimates by phases of care (MIAMOD/PIAMOD). The contract does not have a set-aside designation and the ultimate completion date is February 28, 2018. ISS has...
- This is a $485,000 firm-fixed-price delivery order awarded by the National Cancer Institute (NCI) to the Ontario Institute for Cancer Research (OICR), a non-profit research institute located in Canada. The contract is part of the NCI's Cancer Genome Atlas (TCGA) program, which collects and analyzes tissue samples from various cancer types. Under this award, OICR will provide tissue samples and data to support the TCGA program. The contract has no set-aside designation and is intended to run...
- <p>This is a firm fixed-price purchase order awarded by the National Cancer Institute, a civilian agency, to the National Cancer Center, National Research and Development Agency in Japan. The contract is for $24,000.00 and covers laboratory testing services for the National Cancer Center. The performance period runs from the award date of May 16, 2025 through the ultimate completion date of September 15, 2025. This contract does not have a set-aside designation.</p>
- This federal contract award, valued at $33,483,214.15, was issued by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to the IIT Research Institute (IITRI), a non-profit contract research organization. The contract is for preclinical pharmacology and toxicology studies to support the development of small molecule, biologic, and RNA therapeutic candidates across various disease areas. IITRI has extensive experience providing these services to...
- This is a firm fixed-price purchase order contract awarded by the National Cancer Institute, a civilian federal agency, to the National Cancer Center, a Japanese research and development agency. The contract is for $24,000.00 and requires the awardee to provide laboratory testing services, including whole-genome scans and phenotype data preparation, on 1,000 never-smoking female lung adenocarcinoma cases in Japan. The contract has an ultimate completion date of December 9, 2025. This contract...
- This is a Cost Plus Fixed Fee contract awarded by the National Cancer Institute (NCI), a component of the Department of Health and Human Services, to the IIT Research Institute (IITRI), a non-profit contract research organization. The $23,349,236 contract is for the provision of preclinical in vitro and in vivo screening assays to support the development of cancer preventive agents. IITRI, which has extensive experience supporting the preclinical development of various therapeutics for federal...
- This is a definitive contract awarded by the Department of Health and Human Services' National Institutes of Health National Cancer Institute to the International Union Against Cancer, a non-profit organization, for the International Scientist to Scientist Exchange Program. The contract, which does not have a set-aside designation, has a potential value of $3,494,226.00 and was awarded on April 1, 2004, with a completion date of September 29, 2009. The contract is a cost-no-fee type,...